ESMO Congress 2023
ESMO Congress 2023
Advertisement
Pancreatic Enzyme Replacement Therapy for Patients With Advanced Pancreatic Adenocarcinoma
Katy MarshallESMO Congress 2023 | November 3, 2023
Participating patients received PERT at baseline or within 3 months of receiving first-line treatment.
Read More
CABINET: Does Cabozantinib Benefit Patients With Advanced Pancreatic Neuroendocrine Tumors?
Katy MarshallESMO Congress 2023 | November 3, 2023
Researchers analyzed cabozantinib's ability to improve the progression-free survival rate for patients.
Read More
Advertisement
Advertisement
Advertisement
Latest News

Complete Response to Immunotherapy in HCC: Insights From IMbrave150

March 14, 2025

Dr. Morse Talks About the Significance of World Sleep Day 2025

March 14, 2025

Advancing Therapies Have Improved the Prognosis of Metastatic Melanoma

March 13, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |